Taubert Jennifer L
- SEC CIK
- 0001745938
In the past year, 1 open-market sale filing worth $3.95M and no purchases.
Current role at each company
- JNJ Johnson & JohnsonEVP, WWC. Innovative Medicineas of Aug 18, 2026
- MCD McDonalds CorpDirectoras of Jul 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.95M
- 1 filing
- Net
- −$3.95M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Taubert Jennifer L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
JNJ Johnson & Johnson
EVP, WWC. Innovative Medicine4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 (view filing)6:31 PM ET | Aug 17 | 1 day | Taubert Jennifer LEVP, WWC. Innovative Medicine | SSale | −15.0K | $263.36 | −$3.95M | −7.2%194.5K after | |
| Sep 5, 2025 (view filing) | Sep 4 | 1 day | Taubert Jennifer LEVP, WWC. Innovative Medicine | SSale | −56.5K | $177.81 | −$10.0M | −24.1%178.0K after | |
| Feb 12, 2024 (view filing) | Feb 9 | 3 days | Taubert Jennifer LEVP, WW Chair, Pharmaceuticals | SSale | −59.4K | $156.27 | −$9.28M | −29.6%141.4K after | |
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | Taubert Jennifer LEVP, WW Chair, Pharmaceuticals | SSale | −76.9K | $176.78 | −$13.6M | −37.8%126.5K after |